News | Cardiac Imaging | August 30, 2019

Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019

Company will debut Epiq CVx ultrasound platform in Europe while highlighting integration with LindaCare OnePulse and IntelliSpace Cardiovascular informatics platform to streamline in-hospital and remote follow-up care for patients with cardiac implantable electronic devices

Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019

August 30, 2019 — Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019, Aug. 31–Sept. 4 in Paris, France. At the congress, Philips is showcasing Release 5.0 of its Epiq CVx cardiovascular ultrasound platform for the first time in Europe. The platform includes automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct. Philips also announced that it is collaborating with digital health company LindaCare to combine the latter’s OnePulse cloud-based solution for the remote monitoring of patients with cardiac implantable electronic devices (CIEDs) with the Philips IntelliSpace Cardiovascular informatics platform.

Philips IntelliSpace Cardiovascular is a web-based image and workflow management platform which streamlines the workflow of cardiology departments and across hospitals by consolidating multimodality images and data and enabling access to an open ecosystem of cardiovascular software applications. The seamless combination of IntelliSpace Cardiovascular with LindaCare’s OnePulse solution allows clinicians to more easily access data from their patients’ CIEDs remotely. This results in a more seamless overall workflow, including alert management and triaging, supporting more proactive care. Philips is also introducing a new module on IntelliSpace Cardiovascular which complements the remote monitoring workflow by automating, standardizing and streamlining reporting for patients with CIEDs during hospital visits. Both the OnePulse interface and the new module will be available on the platform later this year. 

Since 2018, Philips has owned a minority interest in LindaCare through Philips Health Technology Ventures. 

At the ESC Congress 2019 Philips is also highlighting the new advanced automation capabilities available on the Epiq CVx cardiology ultrasound platform. By incorporating advanced automation, there is less variability between scans, leading to confident treatment decisions which benefits patients. The new release of Epiq CVx reduces the number of touches of the system by 21 percent in each exam, which is equivalent to more than 400 exams each year (based on eight scans per day over 48 weeks).

The AutoStrain LV application uses advanced Automatic View Recognition technology to identify the different views of the heart, providing high-quality visualization and analysis of left ventricular function – important diagnostic information for patients at risk of developing cardiovascular disease. Also new are the AutoStrain LA and AutoStrain RV applications, which automate the measurement of left atrial and right ventricular longitudinal strain respectively. By creating reliable and reproducible strain measurements for the left ventricle, left atrium and right ventricle, the AutoStrain LV, LA and RV applications support clinicians treating patients with atrial fibrillation, arrhythmia and other complex heart conditions.

During the ESC Congress 2019, Philips will host a Satellite Symposium on Ultrasound featuring worldwide experts. 

For more information: www.usa.philips.com/healthcare

Related Content

An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

News | Cardiac Imaging | April 03, 2020
April 3, 2020 — Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not
Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data

Figure 1: Depiction of the fully automated CT biomarkers tools used in this study. (A) Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data. (B) Case example in an asymptomatic 52-year-old man undergoing CT for colorectal cancer screening. At the time of CT screening, he had a body-mass index of 27·3 and Framingham risk score of 5% (low risk). However, several CT-based metabolic markers were indicative of underlying disease. Multivariate Cox model prediction based on these three CT-based results put the risk of cardiovascular event at 19% within 2 years, at 40% within 5 years, and at 67% within 10 years, and the risk of death at 4% within 2 years, 11% within 5 years, and 27% within 10 years. At longitudinal clinical follow-up, the patient suffered an acute myocardial infarction 3 years after this initial CT and died 12 years after CT at the age of 64 years. (C) Contrast-enhanced CT performed 7 months before death for minor trauma was interpreted as negative but does show significant progression of vascular calcification, visceral fat, and hepatic steatosis. HU=Hounsfield units.

News | Cardiac Imaging | March 06, 2020
March 6, 2020 — Researchers at the National Institutes of Health a
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along with eight other...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Cardiac Imaging | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of ...
SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram.

SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram. Results from an international study presented at #ACC19 show that pressure readings in coronary arteries may identify locations of stenoses remaining after cardiac cath interventions.

Feature | Cardiac Imaging | March 18, 2019 | By Greg Freiherr
As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica
Overlay Init